The Innovation Start- Up Showcase is a Collaboration with BioInnovation Group and Informa’s EBD Group.

There is no doubt! Innovation in life sciences is crucial for advancing scientific discovery and improving the manufacturing of drugs and therapeutics. The BioInnovation Group is a valuable resource for technology companies looking to advance in this field providing insights, guidance, and support from industry leaders to these companies. The 'Innovation Start-up Showcase' promises to be an exciting event, featuring emerging technology companies showcasing their latest advancements and a panel of BioInnovation Group members exchanging thoughts and ideas. This event is a must-attend for anyone interested in the role innovation plays in driving progress for the future of life sciences.

Entrepreneurs and companies actively launching new technologies into the Biopharma market will participate in a “shark tank” style pitch of their technologies while positioned with audience participants plus a panel of expert judges. The audience will receive 6 pitches on new technologies, an interactive Q&A round will follow with the Judges Choice winner then being announced.

Presenting Companies

Enquyst Technologies’ patented Isoelectric Point Purification (IPP) technology enables continuous manufacturing of diverse biological drug products within a single, closed system, while offering unmatched resolving power by precisely separating molecules based on isoelectric point (pI) and charge heterogeneity—the true biophysical fingerprint. This flexible, scalable, and seamlessly integrated downstream solution minimizes yield loss and enables rapid PD and scale-up to increase speed to clinic, transforming the landscape of biopharmaceutical manufacturing.

Kaleidoscope: Kaleidoscope is building software for R&D teams to more easily understand their data, collaborate on their work, and track their most critical decisions. Our tool is an application layer that sits on top of a company's data, connecting the entities (small molecules, proteins, cells, etc.) to the operations (assays, screens, process runs) to the people doing the work. Our platform gives teams a powerful framework to generate dashboards and track progress from actual project timelines and data- and without switching between tools.

Cell X Technologies, Inc, : Cell X provides a platform for intelligent cell processing™ combining robotics, imaging and AI/ML to and to streamline product and process characterization, development and manufacturing of cell & gene therapies. Using precise robotic manipulations and media changes, we apply responsive automation to cell processing, gathering the critical data needed for FDA submissions in a comprehensive 21 CFR part 11 compliant data structure to further improve processes and define product quality metrics.

Advanced Silicon Group: Advanced Silicon Group is developing a photoelectric ELISA that is 15X faster and 15X lower cost than the incumbent technology. Our first product is a biosensor to measure host cell proteins with a rapid and simple measurement.

BioCurie: BioCurie is pioneering a transformative AI-driven, scalable software platform to enable biopharma companies and contract manufacturers to develop and manufacturing high-quality cell, gene, and nucleic acid therapies in a fast, cost-effective manner. The BioCurie Platform^TM conducts millions of experiments in silico to predict and optimize manufacturing conditions to make CGT production faster, better, and cheaper.

Lynne FrickCEO & Co-Founder at BioGuides LLC & BioInnovation GroupSpeaker

Agenda Sessions

At this event

See Lynne at Well Characterized Biologics & Biological Assays

Lynne Frick
CEO & Co-Founder at BioGuides LLC & BioInnovation Group
Speaker